Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy

Saved in:
Bibliographic Details
Published inBlood advances Vol. 8; no. 10; pp. 2327 - 2331
Main Authors Melody, Megan, Epperla, Narendranath, Shouse, Geoffrey, Romancik, Jason, Allen, Pamela, Moyo, Tamara K., Kenkre, Vaishalee, Ollila, Thomas, Fitzgerald, Lindsey, Hess, Brian, David, Kevin, Herr, Megan M., Odetola, Oluwatobi, Lin, Adam, Moreira, Jonathan, Ma, Shuo, Winter, Jane N., Roy, Ishan, Stephens, Deborah, Danilov, Alexey, Shah, Nirav N., Barta, Stefan K., Cortese, Matthew, Cohen, Jonathon B., Gordon, Leo I., Karmali, Reem
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 28.05.2024
Subjects
Adult
Antigens, CD19 - immunology
Female
Humans
Immunotherapy, Adoptive - adverse effects
Immunotherapy, Adoptive - methods
Male
Middle Aged
Neoplasms - immunology
Neoplasms - therapy
Neoplasms, Second Primary - etiology
Neoplasms, Second Primary - therapy
Receptors, Chimeric Antigen
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2473-9529
2473-9537
2473-9537
DOI:10.1182/bloodadvances.2024012573